In this episode, recorded just before the New Year, I discuss recent news in brain cancer research.
This includes:
How the drug loperamide (brand name Imodium), induces cell death in glioblastoma cell lines and if this could have promise for real, human applications.
Metabolic reprogramming via inhibition of a key cancer metabolite-D-2-Hydroxyglutarate (D-2-HG).
Developments of liquid biopsies for glioma.
